Studies have also shown the potential of the DPP-4 inhibitor alogliptin in increasing production of brain-derived neurotrophic factor (BDNF), leading to decrease toxic release of glutamate [67]
Most patients follow a titration schedule over several weeks before reaching a therapeutic dose
LLYs next generation incretin asset, retatrutide , is a once-weekly injection that adds a glucagon agonist to the existing GLP-1/GIP combination in tirzepatide
The BUD is 28 days after punctured
Pair it with Vitamin C: Vitamin C helps your body synthesize and recycle glutathione, making the combination more effective
Talk to your doctor The bottom line, experts say, is not to stay away from GLP-1s but to talk to your doctor including any specialists you see, Chen says about the risks and benefits and to keep the conversation going